Active Pharmaceutical Ingredients (API) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020

Transparency Market 

Research 

Active Pharmaceutical Ingredients (API) Market - Global 

Industry Analysis, Size, Share, Growth, Trends and 

Forecast 2014 - 2020 

Published Date 

2015-03-24 

137 Page Report 

Buy Now 

Request Sample 

Press Release 

Active Pharmaceutical Ingredients Market Expected to Reach USD 

185.9 billion Globally in 2020 

Transparency Market Research 

State Tower, 

90, State Street, Suite 700. 

Albany, NY 12207 

United States 

www.transparencymarketresearch.com 

sales@transparencymarketresearch.com

Active Pharmaceutical Ingredients 

(API) Market 

REPORT DESCRIPTION 

Active Pharmaceutical Ingredients (API) Market 

Size, Share, Growth, Trends and Forecast 2014 – 2020 

- Global Industry Analysis, 

This report analyses the global market for active pharmaceutical ingredients for the period from 

2012 to 2020. The market has been analyzed on the basis of type of API manufacturing (captive 

or in-house and contract manufacturing), type of active pharmaceutical ingredients (synthetic 

chemical API and biological API), type of drugs (branded or innovative prescription drugs, generic 

prescription drugs, and over-the-counter drugs), therapeutic areas, and by geography. The global 

API market is analyzed on the basis of therapeutic areas namely, NSAIDs, oncology drugs, 

diabetes drugs, cardiovascular drugs, central nervous system drugs, musculoskeletal drugs, and 

other drugs (such as antibacterial, antiviral, antifungal drugs, etc.). Also, the market for select 

NSAIDs (paracetamol, ibuprofen, aspirin, and naproxen) has alsbeen analyzed in detail in this 

report. The above mentioned segments are analyzed on the basis of market size in terms of USD 

million and their forecasts for the period 2014 t2020 have alsbeen provided. The CAGR (%) for 

the segments have been estimated for the forecast period from 2014 t2020, considering 2013 as 

the base year. 

The study is a robust combination of primary and secondary research. Primary research formed 

the bulk of our research efforts with information collected from telephonic interviews and 

interactions via e-mails. Secondary research involved study of company websites, annual 

reports, press releases, stock analysis presentations, and various international and national 

databases. The report provides market size in terms of USD million for each segment for the 

period from 2012 t2020, considering the macrand micrenvironmental factors. Growth rates for 

each segment within the global API market have been determined after a thorough analysis of 

past trends, demographics, future trends, technological developments, and regulatory 

requirements. 

Browse the full Active Pharmaceutical Ingredients (API) Market Report 

@ : 


2



Geographically, the global API market has been segmented intfour regions including North 

America, Europe, Asia Pacific and Rest of the World (RoW). Market sizes, forecasts and % CAGR 

for each region have been provided. A qualitative analysis of the market dynamics of the global 

active pharmaceutical ingredients market, which are responsible for driving or restraining the 

growth of this market, along with market opportunities has been described in the market 

overview section of this report. The report alsprovides insights intselect NSAIDs namely, 

paracetamol, ibuprofen, naproxen, and aspirin in terms of volume and revenue for the period 

2012 t2020. 

Browse the full Active Pharmaceutical Ingredients (API) Market press 

release @ : 

http://www.transparencymarketresearch.com/active-pharmaceuticalingredients.html 

http://www.transparencymarketresearch.com/pressrelease/activepharmaceutical-ingredients.htm 

The competitive landscape section of the report includes market share analysis in terms of 

revenue by significant players operating in the global API market for 2013. The study further 

provides Porter’s five force analysis, market attractiveness analysis, and recommendations which 

would be useful for existing and new players tsustain and increase market share in the global 

active pharmaceutical ingredients market. This report concludes with the company profiles 

section in which major players in the global API market have been profiled based on various 

attributes such as company overview, financial overview, product portfolio, business strategies 

and recent/key developments in the market. The global API market is highly fragmented with 

more than 2,500 players. Key companies profiled in the report include Boehringer Ingelheim 

Group, Cambrex Corporation, Dr. Reddy’s Laboratories, Ltd., BASF SE, Hospira, Inc., Lonza Group, 

Mylan, Inc., Novartis AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Actavis plc, and Wuxi 

Apptec. 


3



Get Free Sample Report Active Pharmaceutical Ingredients (API) Market 

Market: 

http://www.transparencymarketresearch.com/sample/sample.php? 

flag=S&rep_id=1690 

The global active pharmaceutical ingredients market is segmented as follows: 

Active Pharmaceutical Ingredients Market, by Type of Manufacturing 

Captive or In-house API manufacturing 

API contract manufacturing 

Active Pharmaceutical Ingredients Market, by Type of API 

Synthetic Chemical API 

Biological API 

Active Pharmaceutical Ingredients Market, by Type of Drug 


4



Branded or Innovative Prescription Drugs 

Generic Prescription Drugs 

Over-the-counter Drugs 

Active Pharmaceutical Ingredients Market, by Therapeutic Area 

Non-steroidal Anti-inflammatory Drugs (NSAIDs) 

Oncology Drugs 

Anti-diabetic Drugs 

Cardiovascular Drugs 

Central Nervous System Drugs 

Musculoskeletal Drugs 

Other Drugs (antibacterial, antiviral, antifungal, etc.) 


5



Active Pharmaceutical Ingredients Market, by Geography 

North America 

Europe 

Asia Pacific 

Rest of the World (RoW) 

TABLE OF CONTENT 

Chapter 1 Preface 

1.1 Report Description 

1.2 Market Segmentation 

1.3 Research Methodology 

1.3.1 Secondary Research 

1.3.2 Primary Research 

1.3.3 Assumptions 

1.4 List of Abbreviations 


6



Chapter 2 Executive Summary 

2.1 Market Snapshot: Global API Market (2013 & 2020) 

2.2 Comparative Analysis: Global API Market Revenue, by Geography, 2013 & 2020 (Value %) 

2.3 Global API Market Revenue, by Therapeutic Area, 2013 (USD Million) 

Chapter 3 Market Overview 

3.1 Introduction 

3.2 Market Dynamics 

3.2.1 Drivers 

3.2.1.1 Increase in Abbreviated New Drug Applications (ANDA) in the recent past boosted the 

demand for APIs 

3.2.1.2 Increase in Drug Master File (DMF) filing from Indian companies indicates a rapid API 

market growth 

3.2.2 Restraints 

3.2.2.1 Strict European Union regulatory policies restraining market growth 

3.2.3 Opportunities 

3.2.3.1 Patent expiry of lucrative biological drugs would provide new opportunities for specialized 

API manufacturers 

3.3 Event Impact Analysis 

3.4 Value Chain Analysis 

3.4.1 Global Active Pharmaceutical Ingredient Market: Value Chain Analysis 


7



3.5 Porter’s Five Forces Analysis: Global Active Pharmaceutical Ingredients Market 

3.5.1 Bargaining Power of Suppliers 

3.5.2 Bargaining Power of Buyers 

3.5.3 Threat of Substitutes 

3.5.4 Threat of New Entrants 

3.5.5 Competitive Rivalry 

3.6 Market Attractiveness Analysis: Global API Market, by Geography 

3.7 Competitive Landscape 

Chapter 4 Global Active Pharmaceutical Ingredients Market, by Types of Manufacturers 

4.1 Overview 

Million) 

4.1.1 Global Active Pharmaceutical Ingredients Market, by Type of Manufacturers, 2012 – 2020 (USD 

4.2 Captive or In-house API Manufacturing 

4.2.1 Global Captive or In-house API Manufacturing Market Revenue, 2012 – 2020 (USD Million) 

4.3 API Contract Manufacturing 

4.3.1 Global API Contract Manufacturing Market Revenue, 2012 – 2020 (USD Million) 

Chapter 5 Global Active Pharmaceutical Ingredients Market, by Type of API 

5.1 Synthetic Chemical API 


8



5.1.1 Differences between Small Molecule APIs and Biological APIs 

5.1.2 Global Synthetic Chemical API Market Revenue, 2012 – 2020 (USD Million) 

5.2 Biological API 

5.2.1 Top 10 drugs – Small Molecule vs. Biological, by API Type, 2008 and 2013 

5.2.2 Global Biological API Market Revenue, 2012 – 2020 (USD Million) 

Chapter 6 Global Active Pharmaceutical Ingredients Market, by Type of Drugs 

6.1 Branded or Innovative Prescription Drugs 

6.1.1 Global Branded or Innovative Prescription Drugs API Market Revenue, 2012 – 2020 (USD Million) 

6.2 Generic Prescription Drugs 

6.2.1 Global Generic Prescription Drugs API Market Revenue, 2012 – 2020 (USD Million) 

6.3 Over-the-counter (OTC) Drugs 

6.3.1 Global Over-the-counter (OTC) Drugs API Market Revenue, 2012 – 2020 (USD Million) 

Chapter 7 Global Active Pharmaceutical Ingredients Market, by Therapeutic Area 

7.1 Overview 

7.1.1 Global Active Pharmaceutical Ingredients Market, by Therapeutic Area, 2012 – 2020 (USD Million) 

7.2 Non-steroidal Anti-inflammatory Drugs 

7.2.1 Global NSAIDs API Market Revenue, 2012 – 2020 (USD Million) 

7.3 Oncology Drugs 


9



7.3.1 Global Oncology Drugs API Market Revenue, 2012 – 2020 (USD Million) 

7.4 Anti-diabetic Drugs 

7.4.1 Global Anti-diabetic Drugs API Market Revenue, 2012 – 2020 (USD Million) 

7.5 Cardiovascular Drugs 

7.5.1 Global Cardiovascular Drugs API Market Revenue, 2012 – 2020 (USD Million) 

7.6 Central Nervous System Drugs 

7.6.1 Global CNS Drugs API Market Revenue, 2012 – 2020 (USD Million) 

7.7 Musculoskeletal drugs 

7.7.1 Global Musculoskeletal Drugs API Market Revenue, 2012 – 2020 (USD Million) 

7.8 Other drugs (antibacterial, antiviral, antifungal, etc.) 

7.8.1 Global Other Drugs API Market Revenue, 2012 – 2020 (USD Million) 

Chapter 8 Global Active Pharmaceutical Ingredients Market, by Geography 

8.1 Overview 

8.1.1 Global Active Pharmaceutical Ingredients Market, by Geography, 2012 – 2020 (USD Million) 

8.2 North America 

8.2.1 North America API Market Revenue, 2012 – 2020 (USD Million) 

8.3 Europe 

8.3.1 Europe API Market Revenue, 2012 – 2020 (USD Million) 

8.4 Asia Pacific 


10



8.4.1 Asia Pacific API Market Revenue, 2012 – 2020 (USD Million) 

8.5 Rest of the World 

8.5.1 Rest of the World API Market Revenue, 2012 – 2020 (USD Million) 

Chapter 9 Global Market Analysis of Select NSAIDs, by Geography 

9.1 Paracetamol 

9.1.1 North America 

9.1.1.1 Demand and Consumption Analysis 

9.1.1.2 North America Paracetamol (APAP) Market Revenue, 2012 – 2020 (USD Million) 

9.1.1.3 North America Paracetamol (APAP) Market Volume, 2012 – 2020 (Metric Tons) 

9.1.2 Europe 


9.1.2.2 Europe Paracetamol (APAP) Market Revenue, 2012 – 2020 (USD Million) 

9.1.2.3 Europe Paracetamol (APAP) Market Volume, 2012 – 2020 (Metric Tons) 

9.1.3 Asia Pacific 


9.1.3.2 Asia Pacific Paracetamol (APAP) Market Revenue, 2012 – 2020 (USD Million) 

9.1.3.3 Asia Pacific Paracetamol (APAP) Market Volume, 2012 – 2020 (Metric Tons) 

9.1.4 Rest of the World 

9.1.4.1 Rest of the World Paracetamol (APAP) Market Revenue, 2012 – 2020 (USD Million) 


11



9.1.4.2 Rest of the World Paracetamol (APAP) Market Volume, 2012 – 2020 (Metric Tons) 

9.2 Ibuprofen 



9.2.1.2 North America Ibuprofen Market Revenue, 2012 – 2020 (USD Million) 

9.2.1.3 North America Ibuprofen Market Volume, 2012 – 2020 (Metric Tons) 

9.2.2 Europe 


9.2.2.2 Europe Ibuprofen Market Revenue, 2012 – 2020 (USD Million) 

9.2.2.3 Europe Ibuprofen Market Volume, 2012 – 2020 (Metric Tons) 



9.2.3.2 Asia Pacific Ibuprofen Market Revenue, 2012 – 2020 (USD Million) 

9.2.3.3 Asia Pacific Ibuprofen Market Volume, 2012 – 2020 (Metric Tons) 


9.2.4.1 Rest of the World Ibuprofen Market Revenue, 2012 – 2020 (USD Million) 

9.2.4.2 Rest of the World Ibuprofen Market Volume, 2012 – 2020 (Metric Tons) 

9.3 Aspirin 




12



9.3.1.2 North America Aspirin Market Revenue, 2012 – 2020 (USD Million) 

9.3.1.3 North America Aspirin Market Volume, 2012 – 2020 (Metric Tons) 

9.3.2 Europe 


9.3.2.2 Europe Aspirin Market Revenue, 2012 – 2020 (USD Million) 

9.3.2.3 Europe Aspirin Market Volume, 2012 – 2020 (Metric Tons) 



9.3.3.2 Asia Pacific Aspirin Market Revenue, 2012 – 2020 (USD Million) 

9.3.3.3 Asia Pacific Aspirin Market Volume, 2012 – 2020 (Metric Tons) 


9.3.4.1 Rest of the World Aspirin Market Revenue, 2012 – 2020 (USD Million) 

9.3.4.2 Rest of the World Aspirin Market Volume, 2012 – 2020 (Metric Tons) 

9.4 Naproxen 



9.4.1.2 North America Naproxen Market Revenue, 2012 – 2020 (USD Million) 

9.4.1.3 North America Naproxen Market Volume, 2012 – 2020 (Metric Tons) 

9.4.2 Europe 



13



9.4.2.2 Europe Naproxen Market Revenue, 2012 – 2020 (USD Million) 

9.4.2.3 Europe Naproxen Market Volume, 2012 – 2020 (Metric Tons) 



9.4.3.2 Asia Pacific Naproxen Market Revenue, 2012 – 2020 (USD Million) 

9.4.3.3 Asia Pacific Naproxen Market Volume, 2012 – 2020 (Metric Tons) 


9.4.4.1 Rest of the World Naproxen Market Revenue, 2012 – 2020 (USD Million) 

9.4.4.2 Rest of the World Naproxen Market Volume, 2012 – 2020 (Metric Tons) 

Chapter 10 Recommendations 

10.1 Enhance manufacturing capacity through acquisitions in targeted geographies 

10.2 Achieve cost leadership in specific API molecules 

Chapter 11 Company Profiles 

11.1 Actavis plc 

11.1.1 Company Overview 

11.1.2 Financial Overview 

11.1.3 Business Strategies 

11.1.4 Recent Developments 


14



11.2 BASF SE 




11.2.4 Recent developments 

11.3 Boehringer Ingelheim Group 





11.4 Cambrex Corporation 





11.5 Dr. Reddy’s Laboratories Ltd. 






15



11.6 Hospira, Inc. 





11.7 Lonza Group 





11.8 Mylan, Inc. 





11.9 Novartis International AG 






16



11.10 Pfizer, Inc. 



11.10.3 Product Portfolio 



11.11 Teva Pharmaceutical Industries Ltd. 





11.12 WuXi Apptec 





List of Figures 

FIG. 1 Active Pharmaceutical Ingredients Market Segmentation 

FIG. 2 Comparative Analysis: Global API Market Revenue, by Geography, 2013 &2020 (Value %) 


17



FIG. 3 Global API Market Revenue, by Therapeutic Area, 2013 (USD Million) 

FIG. 4 Number of DMF Type II applications filed at the U.S. FDA by countries till 2011 

FIG. 5 Global Active Pharmaceutical Ingredient Market: Value Chain Analysis 

FIG. 6 Porter’s Five Forces Analysis: Global Active Pharmaceutical Ingredients Market 

FIG. 7 Market Attractiveness Analysis: Global API Market, by Geography 

FIG. 8 Global Captive or In-house API Manufacturing Market Revenue, 2012 – 2020 (USD Million) 

FIG. 9 Global API Contract Manufacturing Market Revenue, 2012 – 2020 (USD Million) 

FIG. 10 Global Synthetic Chemical API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 11 Top 10 drugs – Small Molecule vs. Biological, by API Type, 2008 and 2013 

FIG. 12 Global Biological API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 13 Global Branded or Innovative Prescription Drugs API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 14 Global Generic Prescription Drugs API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 15 Global Over-the-counter (OTC) Drugs API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 16 Global NSAIDs API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 17 Global Oncology Drugs API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 18 Global Anti-diabetic Drugs API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 19 Global Cardiovascular Drugs API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 20 Global CNS Drugs API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 21 Global Musculoskeletal Drugs API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 22 Global Other Drugs API Market Revenue, 2012 – 2020 (USD Million) 


18



FIG. 23 North America API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 24 Europe API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 25 Asia Pacific API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 26 Rest of the World API Market Revenue, 2012 – 2020 (USD Million) 

FIG. 27 North America Paracetamol (APAP) Market Revenue, 2012 – 2020 (USD Million) 

FIG. 28 North America Paracetamol (APAP) Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 29 Europe Paracetamol (APAP) Market Revenue, 2012 – 2020 (USD Million) 

FIG. 30 Europe Paracetamol (APAP) Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 31 Asia Pacific Paracetamol (APAP) Market Revenue, 2012 – 2020 (USD Million) 

FIG. 32 Asia Pacific Paracetamol (APAP) Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 33 Rest of the World Paracetamol (APAP) Market Revenue, 2012 – 2020 (USD Million) 

FIG. 34 Rest of the World Paracetamol (APAP) Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 35 North America Ibuprofen Market Revenue, 2012 – 2020 (USD Million) 

FIG. 36 North America Ibuprofen Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 37 Europe Ibuprofen Market Revenue, 2012 – 2020 (USD Million) 

FIG. 38 Europe Ibuprofen Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 39 Asia Pacific Ibuprofen Market Revenue, 2012 – 2020 (USD Million) 

FIG. 40 Asia Pacific Ibuprofen Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 41 Rest of the World Ibuprofen Market Revenue, 2012 – 2020 (USD Million) 

FIG. 42 Rest of the World Ibuprofen Market Volume, 2012 – 2020 (Metric Tons) 


19



FIG. 43 North America Aspirin Market Revenue, 2012 – 2020 (USD Million) 

FIG. 44 North America Aspirin Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 45 Europe Aspirin Market Revenue, 2012 – 2020 (USD Million) 

FIG. 46 Europe Aspirin Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 47 Asia Pacific Aspirin Market Revenue, 2012 – 2020 (USD Million) 

FIG. 48 Asia Pacific Aspirin Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 49 Rest of the World Aspirin Market Revenue, 2012 – 2020 (USD Million) 

FIG. 50 Rest of the World Aspirin Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 51 North America Naproxen Market Revenue, 2012 – 2020 (USD Million) 

FIG. 52 North America Naproxen Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 53 Europe Naproxen Market Revenue, 2012 – 2020 (USD Million) 

FIG. 54 Europe Naproxen Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 55 Asia Pacific Naproxen Market Revenue, 2012 – 2020 (USD Million) 

FIG. 56 Asia Pacific Naproxen Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 57 Rest of the World Naproxen Market Revenue, 2012 – 2020 (USD Million) 

FIG. 58 Rest of the World Naproxen Market Volume, 2012 – 2020 (Metric Tons) 

FIG. 59 Actavis plc: Annual Sales Revenue, 2011 – 2013 (USD Million) 

FIG. 60 BASF SE : Annual Sales Revenue of Chemicals, 2012 – 2014 (USD Million) 

FIG. 61 Boehringer Ingelheim: Annual Sales Revenue, 2011 – 2013 (USD Million) 

FIG. 62 Cambrex Corporation: Annual Sales Revenue, 2012 – 2014 (USD Million) 


20



FIG. 63 Dr. Reddy's Laboratories Ltd.: Annual Sales Revenue, 2012 – 2014 (USD Million) 

FIG. 64 Hospira, Inc.: Annual Sales Revenue, 2011 – 2013 (USD million) 

FIG. 65 Lonza Group: Annual Sales Revenue, 2011– 2013 (USD Million) 

FIG. 66 Mylan, Inc.: Annual Sales Revenue, 2011 – 2013 (USD Million) 

FIG. 67 Novartis International AG: Annual Sales Revenue, 2011 – 2013 (USD Million) 

FIG. 68 Pfizer, Inc.: Annual Sales Revenue, 2011 – 2013 (USD Million) 

FIG. 69 Teva, Inc.: Annual Sales Revenue, 2011 – 2013 (USD Million) 

FIG. 70 WuXi PharmaTech (Cayman), Inc.: Annual Sales Revenue, 2011 – 2013 (USD Million) 

List of Tables 

TABLE 1 List of Abbreviations 

TABLE 2 Market Snapshot: Global API Market (2013 & 2020) 

TABLE 3 Patent Expiry of Major Pharmaceutical Drugs, 2009 - 2014 

TABLE 4 Patent Expiry of Major Biological Drugs in the U.S. and EU 

TABLE 5 Event Impact Analysis: Global API Market 

TABLE 6 Competitive Landscape: Global API Market, 2013 (USD Million) 

TABLE 7 Global Active Pharmaceutical Ingredients Market, by Type of Manufacturers, 2012 – 2020 (USD 

Million) 

TABLE 8 Differences between Small Molecule APIs and Biological APIs 

TABLE 9 Global Active Pharmaceutical Ingredients Market, by Therapeutic Area, 2012 – 2020 (USD Million) 


21



TABLE 10 Global Active Pharmaceutical Ingredients Market, by Geography, 2012 – 2020 (USD Million) 

TABLE 11 Actavis plc: Expenses & Revenue, 2011 – 2013 (USD Million) 

TABLE 12 BASF SE: Expenses & Revenue, 2012 – 2014 (USD Million) 

TABLE 13 Cambrex Corporation: Expenses & Revenue, 2011 – 2013 (USD Million) 

TABLE 14 Dr. Reddy's Laboratories Ltd: Expenses & Revenue, 2012 – 2014 (USD Million) 

TABLE 15 Hospira, Inc.: Expenses & Revenue, 2011 – 2013 (USD Million) 

TABLE 16 Mylan, Inc..: Expenses & Revenue, 2011 – 2013 (USD Million) 

TABLE 17 Novartis International AG: Expenses & Revenue, 2011 – 2013 (USD Million) 

TABLE 18 Pfizer, Inc.: Expenses & Revenue, 2011 – 2013 (USD Million) 

TABLE 19 Teva, Inc.: Expenses & Revenue, 2011 – 2013 (USD Million) 

TABLE 20 WuXi PharmaTech, (Cayman), Inc.: Expenses & Revenue, 2011 – 2013 (Thousand USD) 

Browse All Pharmaceutical Market Research Reports @ 

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html 

About Us 

Transparency Market Research is a market intelligence company providing global business information 

reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking 

insight for thousands of decision makers. 

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use 

proprietary data sources and various tools and techniques to gather, and analyze information. Our 

business offerings represent the latest and the most reliable information indispensable for businesses to 

sustain a competitive edge. 


22



Contact 


90 State Street, 

Suite 700, 

Albany 

NY - 12207 

United States 

Tel: +1-518-618-1030 

USA - Canada Toll Free 866-552-3453 

Email: sales@transparencymarketresearch.com 

Website: http://www.transparencymarketresearch.com/ 

Browse The Market Research Blog : 

http://researchandreports.wordpress.com/ http://www.transparencymarketresearch.com 


23

Active Pharmaceutical Ingredients (API) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?